New PMPRB rules restrict who can trigger reviews and shift focus to inflation and global price gaps
Canadian trial finds common medicine may aid memory in Parkinson's-related dementia cases
GreenShield's Essential Medicines program targets Canadians without coverage, offering up to $1,000 in drug support
Plan sponsors face mounting pressure as $1m rare disease drug loses public coverage in BC
Semaglutide, the ingredient in Ozempic and Wegovy, will soon move to generic status in Canada and consultants hope this sparks plan sponsors to take a proactive approach to weight management
Employers urged to address stigma and rethink benefits for workers with obesity
